Tango Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
TNGX chart
What traders are saying about $TNGX
Latest postsTango Therapeutics, Inc. news
- JP Morgan maintains Tango Therapeutics at Overweight, raises price target to $47 from $46
TradingView ·
- Wedbush maintains Tango Therapeutics at Outperform, lowers price target to $40 from $45
TradingView ·
- Jefferies raises Tango Therapeutics stock price target on trial data By Investing.com
Investing.com India ·
- Tango Therapeutics at guggenheim healthcare conference: late-stage push By Investing.com
Investing.com Nigeria ·
- JPMorgan raises Tango Therapeutics price target to $47 on pipeline
Investing.com ·
- HC Wainwright & Co. maintains Tango Therapeutics at Buy, lowers price target to $67 from $68
TradingView ·
- Candriam S.C.A. Sells 1,152,632 Shares of Tango Therapeutics, Inc. $TNGX
MarketBeat ·
- Tango Therapeutics reports strong Phase 1/2 pan...
Pluang ·
- Tango Therapeutics Swings to Q3 Net Loss
Moomoo ·
- Tango Therapeutics, Inc. Stock 12‑Month Price Target Cut to $46.64, Implies 117% Upside
TradingView ·
- Tango Therapeutics earnings on deck after ESMO data readout
Investing.com ·
- Tango Therapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
Tango Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $62.4M | $42.1M | $36.5M | $24.9M |
| Net income | -$101.6M | -$130.3M | -$101.7M | -$108.2M |
| Diluted EPS | $-0.87 | $-1.19 | $-1.08 | $-1.23 |
| Total assets (year end) | $398.7M | $316.5M | $402.6M | $436.5M |
| Cash and equivalents (year end) | $112.3M | $69.5M | $66.4M | $60.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Tango Therapeutics, Inc.
- Ticker
- TNGX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1819133
- Former names
- BCTG Acquisition Corp.
Frequently asked questions
What exchange is Tango Therapeutics, Inc. listed on?
Tango Therapeutics, Inc. trades on the Nasdaq under the ticker symbol TNGX.
What industry is Tango Therapeutics, Inc. in?
Tango Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Tango Therapeutics, Inc. headquartered?
Tango Therapeutics, Inc.'s business address on file with the SEC is in Boston, MA.
When does Tango Therapeutics, Inc.'s fiscal year end?
Tango Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Tango Therapeutics, Inc. report?
Tango Therapeutics, Inc. reported $62.4M in revenue for calendar year 2025, according to its SEC filings.